WHEN A HEART TRANSPLANT IS NOT SUFFICIENT: RECURRENT GIANT CELL MYOCARDITIS
Eitan Frankel(Thomas Jefferson University Hospital), Yevgeniy Brailovsky(Thomas Jefferson University Hospital), H. Todd Massey(Thomas Jefferson University), Ilya Danelich(AstraZeneca (South Korea)), Indranee Rajapreyar(Tufts Medical Center), Arwa Omary(Thomas Jefferson University Hospital), J. Eduardo Rame(Thomas Jefferson University Hospital), Justin Pelberg(Thomas Jefferson University Hospital), R.J. Alvarez(Thomas Jefferson University Hospital), Vakhtang Tchantchaleishvili(Thomas Jefferson University Hospital), Jennifer Mazzoni Clifford(Thomas Jefferson University Hospital), Mahek Shah(Lehigh Valley Hospital-Pocono)
Cited by 0
Related Papers
Time to Anticoagulation Reversal and Outcomes After Intracerebral Hemorrhage
|JAMA Neurology|2024|88
Practical Management of Postoperative Atrial Fibrillation after Noncardiac Surgery
|Journal of the American College of Surgeons|2014|73
Safety of Nonsteroidal Antiinflammatory Drugs in Patients with Cardiovascular Disease
|Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy|2015|55
Role of clinical pharmacists and pharmacy support personnel in transitions of care
|JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY|2020|40
Impact of the Pharmacy Practice Model Initiative on Clinical Pharmacy Specialist Practice
|Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy|2016|29